CD19 and B-cell non-Hodgkin lymphoma: In this article, we report a patient with B cell lymphoma that was subsequently diagnosed with MM during disease progression who was treated with CD19-CAR T cell and BCMA-CAR T cell therapy, and her disease was effectively controlled.